Eligibility and Supervised Use Saxenda is particularly recommended for individuals with a Body Mass Index (BMI) exceeding 30 kg/m, or for those with a BMI over 27 kg/m accompanied by chronic conditions such as hypertension, type 2 diabetes, or hyperlipidemia
Postural Orthostatic Tachycardia Syndrome (POTS) A POTS patient who needed to take 2-3 xs more time to do her college work, reported she no longer had brain fog and was able to do her work in a third of the time
Ivy Rx takes a different approach
It is extremely beneficial to us its main purpose is to protect the cells of our bodies from harmful toxins, explains Kelly Saynor, aesthetic nurse and founder of Prfkt
88 Hashimoto, S
Key Takeaways on Wegovy Insurance Coverage FDA-approved for weight management : Wegovy (semaglutide 2.4mg) is approved for chronic weight management in adults with BMI 30, or BMI 27 with at least one weight-related comorbidity Commercial insurance coverage is expanding : About 40-50% of employer-sponsored plans now cover GLP-1 medications for weight loss, up from under 20% in 2023 Medicare does NOT cover Wegovy for weight loss : Federal law prohibits Medicare Part D from covering drugs prescribed solely for weight management no exceptions List price without insurance : Approximately $1,349/month ($16,188/year) at retail pharmacy Savings programs available : Novo Nordisk offers a savings card reducing cost to as low as $0-$25/month for eligible commercially insured patients Wegovy is a once-weekly injectable prescription medication containing semaglutide at the 2.4mg dose, manufactured by Novo Nordisk
